Treatment of recalcitrant squamous carcinoma in situ of penis with tapering imiquimod 5-3.75% cream.

Authors:
Dario Didona
Dario Didona
"La Sapienza" University
Italy
Andrea Sechi
Andrea Sechi
Sorbonne Universités UPMC Univ Paris 06
Augusto Orlandi
Augusto Orlandi
Institute of Anatomic Pathology
Atlanta | United States
Luca Bianchi
Luca Bianchi
Policlinic Tor Vergata

Dermatol Ther 2019 May 22;32(3):e12904. Epub 2019 Apr 22.

Dermatology Department, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.12904DOI Listing
May 2019
1 Read

Publication Analysis

Top Keywords

carcinoma situ
4
situ penis
4
tapering imiquimod
4
penis tapering
4
imiquimod 5-375%
4
squamous carcinoma
4
5-375% cream
4
treatment recalcitrant
4
recalcitrant squamous
4
5-375%
1
cream
1
imiquimod
1
penis
1
squamous
1
carcinoma
1
situ
1
treatment
1
tapering
1

References

(Supplied by CrossRef)
Penile cancer: Epidemiology, pathogenesis and prevention
Bleeker M. C. et al.
World Journal of Urology 2009
Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis
Cook‐Bolden F et al.
Journal of The American Academy of Dermatology 2002
Imiquimod in the treatment of penile intraepithelial neoplasia: An update
Deen K. et al.
Australasian Journal of Dermatology 2017
Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream
Schroeder T. L. et al.
Journal of the American Academy of Dermatology 2002
Bowen's disease of the penis treated with topical imiquimod 5% cream
Taliaferro S. J. et al.
Journal of Drugs in Dermatology 2008

Similar Publications